logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Sun Pharmaceutical Industries Limited


USPTO Granted Patents = 155

% Expired Patents = 26.5



Trademarks = 99

Forward Citations = 281

Loading Chart...
Loading Chart...

255 inventors (with patents filed for the assignee):

goldMedal Rajamannar Thennati (37 out of 46 patents)

silverMedal Subhas Balaram Bhowmick (35 out of 44 patents)

bronzeMedal Prashant Kane (31 out of 35 patents)

4.  Samarth Kumar (27 out of 27 patents)

5.  Romi Barat Singh (23 out of 26 patents)

6.  Mohan Prasad (13 out of 43 patents)

7.  Sudeep Kumar Agrawal (9 out of 10 patents)

8.  Maheshkumar Parasmal Soni (9 out of 9 patents)

9.  Kirti Ganorkar (8 out of 9 patents)

10.  Muthukumaran Natarajan (8 out of 9 patents)

11.  Satish Kumar Jain (8 out of 9 patents)

12.  Vinod Sampatrao Burade (7 out of 7 patents)

13.  Dhiren Rameshchandra Joshi (7 out of 7 patents)

14.  Krunal Harishbhai Soni (7 out of 7 patents)

15.  Abhishek Tiwari (7 out of 7 patents)


Core Competencies:
Parenteral Dosage Forms
Infusion Systems
GLP-1 Analogues
Dihydroergotamine
Amiodarone
Ranolazine
Duloxetine
Octreotide
JAK Inhibitors
Deuterated D-Serine
Topical Formulations
Extended Release

155 patents:

1. 12703704 - Process for preparing a composition comprising enantiomerically enriched pyrrolo[2,3-d]pyrimidines (2026-08-11),
2. 12667735 - Methods for reducing pain during photodynamic therapy of actinic keratosis (2026-06-30),
3. 12643902 - Process for preparing enantiomerically enriched substituted pyrrolo[2,3-d]pyrimidines (2026-06-02),
4. 12622948 - GLP-1/GIP DUAL AGONISTS (2026-05-12),
5. 12533351 - Parenteral unit dosage form of dihydroergotamine (2026-01-27),
6. 12533316 - Parenteral dosage form of amiodarone (2026-01-27),
7. 12508269 - Parenteral dosage form of carboplatin (2025-12-30),
8. 12473252 - Processes for the preparation of deuterated D-serine (2025-11-18),
9. 12421289 - GLP-1 analogues (2025-09-23),
10. 12403070 - Intravenous infusion dosage form (2025-09-02),
11. 12364699 - Method of treating hair loss disorders (2025-07-22),
12. 12350475 - Method of injecting octreotide acetate into the body (2025-07-08),
13. 12325707 - Process for preparing enantiomerically enriched JAK inhibitors (2025-06-10),
14. 12296011 - Methods for photodynamic therapy (2025-05-13),
15. 12290700 - Adjustable illuminator for photodynamic therapy and diagnosis (2025-05-06),
Sun Pharmaceutical Industries Limited, headquartered in Princeton, NJ, specializes in the development and manufacturing of pharmaceutical formulations. The company focuses on a range of core technologies, including parenteral dosage forms and infusion systems, as well as therapeutic areas involving GLP-1 analogues and various medications such as dihydroergotamine, amiodarone, ranolazine, duloxetine, and octreotide. Sun Pharma is committed to advancing healthcare through innovative solutions and high-quality products.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Sun Pharmaceutical Industries Limited
155 Patents

#13 in Princeton, NJ

#119 in New Jersey

#2,555 in US

#5,282 in the World

Princeton, NJ (US)
Princeton, NJ, United States of America

Sun Pharmaceutical Industries Limited

Forward Citations = 281

255 inventors:

goldMedal Rajamannar Thennati (37 out of 46 patents)

silverMedal Subhas Balaram Bhowmick (35 out of 44 patents)

bronzeMedal Prashant Kane (31 out of 35 patents)

4.  Samarth Kumar (27 out of 27 patents)

5.  Romi Barat Singh (23 out of 26 patents)

Please report any incorrect information to [email protected]
Loading…